David Mandelman

Title: David Mandelman: Innovator in Nucleic Acid Technologies

Introduction

David Mandelman is a prominent inventor based in Carlsbad, California. He has made significant contributions to the field of molecular biology, particularly in the development of high-fidelity proteins for nucleic acid amplification methods. With a total of 3 patents to his name, Mandelman continues to push the boundaries of innovation in his field.

Latest Patents

Mandelman's latest patents include groundbreaking work on SSB-polymerase fusion proteins. These fusion proteins comprise a single-strand DNA binding protein and a nucleic acid polymerase, such as DNA polymerase or reverse transcriptase. They are designed for use in nucleic acid amplification methods, including the polymerase chain reaction (PCR). Another notable patent involves mutant DNA polymerases, specifically an isolated mutant Tfi DNA polymerase with a D144A point mutation. This polymerase is versatile and can be utilized in various methods, including nucleic acid synthesis, DNA sequencing, nucleic acid amplification, and cDNA synthesis.

Career Highlights

David Mandelman is currently associated with Life Technologies Corporation, where he applies his expertise in molecular biology to develop innovative solutions. His work has been instrumental in advancing techniques that are essential for genetic research and diagnostics.

Collaborations

Mandelman has collaborated with notable colleagues, including Jun E Lee and Robert Jason Potter. These partnerships have fostered a collaborative environment that enhances the development of new technologies in the field.

Conclusion

David Mandelman is a key figure in the realm of nucleic acid technologies, with a focus on high-fidelity proteins and mutant DNA polymerases. His contributions continue to impact the scientific community and advance the field of molecular biology.